Links between SNPs in TLR-2 and TLR-4 and idiopathic recurrent pregnancy loss

References

• American College of O, Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American college of obstetricians and gynecologists. Int J Gynaecol Obstet. 2002;78:179–190.
   PubMedGoogle Scholar
• Hyde KJ, Schust DJ. Genetic considerations in recurrent pregnancy loss. Cold Spring Harb Perspect Med. 2015;5:a023119.
   PubMed Web of Science ®Google Scholar
• Bao SH, Shuai W, Tong J, et al. Increased expression of toll-like receptor 3 in decidual natural killer cells of patients with unexplained recurrent spontaneous miscarriage. Eur J Obstet Gynecol Reprod Biol. 2012;165:326–330.
   PubMed Web of Science ®Google Scholar
• Hirschfeld AF, Jiang R, Robinson WP, et al. Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage. Hum Reprod. 2007;22:440–443.
   PubMed Web of Science ®Google Scholar
• Koga K, Mor G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol. 2010;63:587–600.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2016;50:1–17.
   PubMed Web of Science ®Google Scholar
• Wujcicka W, Wilczynski J, Nowakowska D. SNPs in toll-like receptor (TLR) genes as new genetic alterations associated with congenital toxoplasmosis? Eur J Clin Microbiol Infect Dis. 2013;32:503–511.
   PubMed Web of Science ®Google Scholar
• Xie H, Sheng L, Zhou H, et al. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Br J Haematol. 2014;164:165–176.
   PubMed Web of Science ®Google Scholar
• Weng PH, Huang YL, Page JH, et al. Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. PLoS One. 2014;9:e110569.
   PubMed Web of Science ®Google Scholar
• Pineda A, Verdin-Teran SL, Camacho A, et al. Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch Med Res. 2011;42:382–391.
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S, et al. Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? Immunol Lett. 2004;92:207–214.
   PubMed Web of Science ®Google Scholar
• Kamiyama S, Teruya Y, Nohara M, et al. Impact of detection of bacterial endotoxin in menstrual effluent on the pregnancy rate in in vitro fertilization and embryo transfer. Fertil Steril. 2004;82:788–792.
   PubMed Web of Science ®Google Scholar
• Clark DA, Yu G, Arck PC, et al. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol. 2003;49:297–307.
   PubMed Web of Science ®Google Scholar
• Clark DA, Manuel J, Lee L, et al. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-alpha + IFN-gamma) on pregnancy loss. Am J Reprod Immunol. 2004;52:370–378.
   PubMed Web of Science ®Google Scholar
• Deb K, Chaturvedi MM, Jaiswal YK. A ‘minimum dose’ of lipopolysaccharide required for implantation failure: assessment of its effect on the maternal reproductive organs and interleukin-1alpha expression in the mouse. Reproduction. 2004;128:87–97.
   PubMed Web of Science ®Google Scholar
• Kolben TM, Rogatsch E, Hester A, et al. Involvement of ILR4alpha and TLR4 in miscarriages. J Reprod Immunol. 2019;131:36–43.
   PubMed Web of Science ®Google Scholar
• Razdaibiedina A, Khobzey M, Tkachenko V, et al. Effects of single-nucleotide polymorphisms in cytokine, toll-like receptor, and progesterone receptor genes on risk of miscarriage. Obstet Gynecol Int. 2018;2018:9272749.
   PubMed Web of Science ®Google Scholar
• Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2007;4:444–454.
   PubMedGoogle Scholar
• Molvarec A, Jermendy A, Kovacs M, et al. Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population. Hypertens Res. 2008;31:859–864.
   PubMed Web of Science ®Google Scholar
• Pandey S, Mittal RD, Srivastava M, et al. Impact of toll-like receptors [TLR] 2 (−196 to −174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol. 2009;114:501–505.
   PubMed Web of Science ®Google Scholar
• Ojeda-Ojeda M, Martinez-Garcia MA, Alpanes M, et al. Association of TLR2 S450S and ICAM1 K469E polymorphisms with polycystic ovary syndrome (PCOS) and obesity. J Reprod Immunol. 2016;113:9–15.
   PubMed Web of Science ®Google Scholar
• Li P, Wu HL, Dong BH. Relationship between TLR4 and CCL2 expression and recurrent spontaneous abortion. Genet Mol Res. 2016;15:gmr6882.
   Web of Science ®Google Scholar
• Jiao Y, Zhao J, Hu B, et al. Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang. Exp Ther Med. 2016;12:3268–3274.
   PubMed Web of Science ®Google Scholar
• Wujcicka W, Paradowska E, Studzinska M, et al. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women. Virol J. 2017;14:64.
   PubMed Web of Science ®Google Scholar
• Liu J, Radler D, Illi S, et al. TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy. 2011;66:1020–1029.
   PubMed Web of Science ®Google Scholar
• Taniguchi R, Koyano S, Suzutani T, et al. Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis. 2013;17:e1092–1097.
   PubMed Web of Science ®Google Scholar
• Qiu X, Dong Y, Cao Y, et al. Correlation between TLR2, TLR3, TLR4, and TLR9 polymorphisms and susceptibility to and prognosis of severe hepatitis among the newborns. J Clin Lab Anal. 2018;32:e22292.
   Web of Science ®Google Scholar
• Royse KE, Kempf MC, McGwin G Jr., et al. Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. J Reprod Immunol. 2012;96:84–89.
   PubMed Web of Science ®Google Scholar
• Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12:683–691.
   PubMed Web of Science ®Google Scholar
• Ryckman KK, Williams SM, Krohn MA, et al. Genetic association of toll-like receptor 4 with cervical cytokine concentrations during pregnancy. Genes Immun. 2009;10:636–640.
   PubMed Web of Science ®Google Scholar
• Kolz M, Baumert J, Muller M, et al. Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol. BMC Med Genet. 2008;9:9.
   PubMed Web of Science ®Google Scholar
• Semlali A, Reddy Parine N, Arafah M, et al. Expression and polymorphism of toll-like receptor 4 and effect on NF-kappaB mediated inflammation in colon cancer patients. PLoS One. 2016;11:e0146333.
   PubMed Web of Science ®Google Scholar
• Semlali A, Jalouli M, Parine NR, et al. Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women. Onco Targets Ther. 2017;10:1207–1216.
   PubMed Web of Science ®Google Scholar
• Urcelay E, Blanco-Kelly F, de Las Heras V, et al. TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population. J Neuroimmunol. 2007;192:215–218.
   PubMed Web of Science ®Google Scholar
• Ryckman KK, Williams SM, Krohn MA, et al. Interaction between interleukin-1 receptor 2 and toll-like receptor 4, and cervical cytokines. J Reprod Immunol. 2011;90:220–226.
   PubMed Web of Science ®Google Scholar